WHO Africa Launches Regional Health Data Hub for 47 Countries

The World Health Organization's Regional Office for Africa has launched a new digital platform to unify fragmented health data across 47 Member States into actionable intelligence for better decision-making.

FE
FIRAT EditorialResearch Contributor
Aug 31, 2026
3 min read
Share:
WHO Africa Launches Regional Health Data Hub for 47 Countries

WHO Africa Launches Regional Health Data Hub for 47 Countries

On August 27, the World Health Organization (WHO) Regional Office for Africa launched the Regional Health Data Hub in Addis Ababa — a new digital platform designed to consolidate fragmented health data across all 47 Member States into a single, interoperable system for evidence-based decision-making.

The Problem of Fragmented Data

Across the African continent, governments make critical health decisions daily — from responding to disease outbreaks to planning maternal health services — yet the information they need is scattered across multiple systems. Efforts to reduce maternal deaths, for example, depend on combining data on antenatal care, skilled birth attendance, emergency obstetric services, health workforce availability, and medicine supplies, data that are often stored in separate, incompatible systems.

What the Hub Does

The Regional Health Data Hub brings together these datasets into one platform that enables governments, public health institutions, researchers, and development partners to:

  • Access harmonized health information across maternal, newborn, child, and adolescent health, noncommunicable diseases, infectious diseases, and health systems
  • Monitor trends and compare progress through interactive dashboards, maps, and analytical tools
  • Generate insights using advanced analytics and artificial intelligence capabilities for forecasting and trend analysis
  • Explore real-time dashboards that allow users to assess health systems functionality and performance, monitor health status and trends, evaluate disease burden, and identify health inequalities

The platform currently offers more than 505 datasets and covers a population of over 1.33 billion people.

Retaining National Ownership

A key feature of the Hub is that it complements rather than replaces existing national health information systems. Countries retain full ownership of their data while benefiting from common standards that improve interoperability, strengthen data quality, and support secure information sharing. A regional governance framework under development will further promote transparency, accountability, and responsible data stewardship.

Leadership Perspective

"No health decision in our region should be taken in the dark," said Dr. Mohamed Yakub Janabi, WHO Regional Director for Africa. "Every policy, every investment and every action to improve people's health should be guided by reliable evidence. The Regional Health Data Hub reflects our commitment to ensuring that countries have timely access to the evidence they need to anticipate challenges, direct resources where they are needed most and improve the health and well-being of their populations."

Why It Matters

Better data alone do not improve people's health — better decisions do. By giving countries faster access to reliable, integrated, and actionable health information, the Regional Health Data Hub will help transform data into evidence, evidence into action, and action into better health outcomes for millions of people across the African Region.

The Hub will also incorporate advanced analytics and AI-enabled capabilities that support forecasting, trend analysis, and evidence generation. As additional datasets, indicators, and analytical tools are introduced through a phased approach, the Hub will continue to expand its ability to support proactive planning, better resource allocation, and more resilient health systems across the Region.


Source: WHO Regional Office for Africa, August 27, 2026.

Filed Under:#WHO#health data#digital health#Africa#health information systems#data-driven decision-making

Share this research insight

Help circulate peer-reviewed evidence and institutional briefings.

Share:
FE
Author Spotlight

FIRAT Editorial

Research Contributor · Foresight Institute of Research and Translation

FIRAT Editorial contributes to FIRAT's mission of generating evidence-based research and translating scientific breakthroughs into sustainable African development.

Focus:ResearchInnovationDevelopment
More Research

Related Articles in Life Science and Humanity (LSH)

View all in LSH
WHO Keeps Polio Emergency in Place as Virus Survives Low Season in Afghanistan and Pakistan
LSHAug 27, 2026

WHO Keeps Polio Emergency in Place as Virus Survives Low Season in Afghanistan and Pakistan

The World Health Organization's Emergency Committee has unanimously agreed to maintain polio as a Public Health Emergency of International Concern, warning that wild poliovirus persisted through the winter low season in core reservoirs and that vaccine-derived strains continue to spread across Africa.

By FIRAT Editorial Board
Tracking the Clade Ib Mpox Lineage in Central Africa: Real-Time Genomic Surveillance, APOBEC3 Mutations, and Ring Vaccination Deployment
LSHAug 24, 2026

Tracking the Clade Ib Mpox Lineage in Central Africa: Real-Time Genomic Surveillance, APOBEC3 Mutations, and Ring Vaccination Deployment

Real-time genomic sequencing and multicenter epidemiological surveillance across the Democratic Republic of the Congo, Rwanda, Burundi, and Uganda reveal how the newly emerged Clade Ib monkeypox virus lineage—characterized by distinctive host APOBEC3 cytidine deaminase mutation signatures—is driving sustained human-to-human transmission across cross-border mining and commercial corridors, triggering targeted ring vaccination with MVA-BN and clinical trials of next-generation mRNA vaccines.

By FIRAT Editorial Board
Maternal RSV Immunization Breakthrough: NEJM MATISSE Trial and African Antenatal Care Implementation Prove 81.8% Infant Protection Against Severe Bronchiolitis
LSHAug 24, 2026

Maternal RSV Immunization Breakthrough: NEJM MATISSE Trial and African Antenatal Care Implementation Prove 81.8% Infant Protection Against Severe Bronchiolitis

Pivotal Phase 3 MATISSE trial results published in The New England Journal of Medicine and operationalized across South Africa, Kenya, and The Gambia confirm that the bivalent prefusion F maternal RSV vaccine (RSVpreF) delivers 81.8% efficacy against severe lower respiratory tract illness in infants during their first 90 days of life and 69.4% through 6 months, leveraging transplacental IgG transfer to prevent thousands of pediatric hospitalizations across low- and middle-income nations.

By FIRAT Editorial Board